JoVE Visualize What is visualize?
Stop Reading. Start Watching.
Advanced Search
Stop Reading. Start Watching.
Regular Search
Find video protocols related to scientific articles indexed in Pubmed.
Impact of night sleep duration on glycemic and triglyceride levels in Chinese with different glycemic status.
J Diabetes
PUBLISHED: 05-28-2014
Show Abstract
Hide Abstract
The aim of the present study was to assess the relationship between night sleep duration and glycemic and triglyceride (TG) levels among people with different glycemic status.
Related JoVE Video
Weight-neutral effect of once-daily insulin detemir in Chinese type 2 diabetes patients: Subgroup analysis of the SOLVE study.
J Diabetes
PUBLISHED: 05-03-2014
Show Abstract
Hide Abstract
The present subanalysis of the Study of Once Daily Levemir (SOLVE) study was to evaluate the safety and efficacy of once-daily insulin detemir as add-on to oral antidiabetic drugs (OADs) in Chinese type 2 diabetes patients according to body mass index in a real-life setting.
Related JoVE Video
[Etiologies of 1 173 hospitalized cases with adrenal incidentaloma].
Zhonghua Yi Xue Za Zhi
PUBLISHED: 04-26-2014
Show Abstract
Hide Abstract
To summarize the characteristics of etiological distribution of adrenal incidentaloma during the past 20 years.
Related JoVE Video
Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial.
Am. Heart J.
PUBLISHED: 03-17-2014
Show Abstract
Hide Abstract
Patients with cardiovascular disease and impaired glucose tolerance are at increased risk of cardiovascular events and type 2 diabetes mellitus (T2DM). Lifestyle modification or pharmacological intervention can delay progression to T2DM, but there is no clear evidence that they reduce cardiovascular risk in this population. Acarbose, an ?-glucosidase inhibitor that lowers postprandial blood glucose, has been shown to reduce T2DM risk by 25%, and possibly cardiovascular risk in impaired glucose tolerance subjects without cardiovascular disease.
Related JoVE Video
Effects of telmisartan on lipid metabolisms and proinflammatory factors secretion of differentiated 3T3-L1 adipocytes.
J Renin Angiotensin Aldosterone Syst
PUBLISHED: 03-05-2014
Show Abstract
Hide Abstract
Aim:To investigate the effect of telmisartan on the lipometabolisms and the proinflammatory factors secreted from 3T3-L1 adipocytes and to explore the possible mechanisms.
Related JoVE Video
Waist-to-Hip Ratio, Dyslipidemia, Glycemic Levels, Blood Pressure and Depressive Symptoms among Diabetic and Non-Diabetic Chinese Women: A Cross-Sectional Study.
PLoS ONE
PUBLISHED: 01-01-2014
Show Abstract
Hide Abstract
To explore the relationship between depressive symptoms and waist-to-hip ratio, dyslipidemia, glycemic levels or blood pressure among diabetic and non-diabetic Chinese women.
Related JoVE Video
Safety of once-daily insulin detemir in patients with type 2 diabetes treated with oral hypoglycemic agents (OHAs) in routine clinical practice.
J Diabetes
PUBLISHED: 03-17-2013
Show Abstract
Hide Abstract
The objective was to identify demographic and treatment factors that were predictive of hypoglycemia in a large cohort of type 2 diabetic patients initiating insulin detemir.
Related JoVE Video
Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients.
Am. J. Med.
PUBLISHED: 02-20-2013
Show Abstract
Hide Abstract
Individually, diabetes mellitus, hypertension, and dyslipidemia have been shown to increase the risk of cardiovascular disease. While traditional management of Type 2 diabetes has focused mainly on glycemic control, robust evidence supports the integration of hypertension and dyslipidemia management to reduce the risk of cardiovascular disease. The primary objective of this study was to assess the level of control of blood glucose, blood pressure, and blood lipids (3Bs) among patients with type 2 diabetes. An additional objective was to investigate the impact of hospital type, physician specialty, treatment pattern, and patient profile on clinical outcomes.
Related JoVE Video
Pituitary stalk interruption syndrome in Chinese people: clinical characteristic analysis of 55 cases.
PLoS ONE
PUBLISHED: 01-14-2013
Show Abstract
Hide Abstract
Pituitary stalk interruption syndrome (PSIS) is characterized by the absence of pituitary stalk, pituitary hypoplasia, and ectopic posterior pituitary. Due to the rarity of PSIS, clinical data are limited, especially in Chinese people. Herein, we analyzed the clinical characteristics of patients diagnosed with PSIS from our center over 10 years.
Related JoVE Video
Does glycemic control offer similar benefits among patients with diabetes in different regions of the world? Results from the ADVANCE trial.
Diabetes Care
PUBLISHED: 10-04-2011
Show Abstract
Hide Abstract
Participants in ADVANCE were drawn from many countries. We examined whether the effects of intensive glycemic control on major outcomes in ADVANCE differ between participants from Asia, established market economies (EMEs), and eastern Europe.
Related JoVE Video
A Chinese diabetes risk score for screening of undiagnosed diabetes and abnormal glucose tolerance.
Diabetes Technol. Ther.
PUBLISHED: 03-15-2011
Show Abstract
Hide Abstract
This study is aimed at developing and evaluating a diabetes risk score (DRS) to predict incident diabetes and screen for undiagnosed diabetes and abnormal glucose tolerance in the Chinese population.
Related JoVE Video
A patient with essential hypernatremia had good response to desmopressin acetate therapy.
Neuro Endocrinol. Lett.
PUBLISHED: 06-29-2010
Show Abstract
Hide Abstract
Essential hypernatremia is very rare in clinical practice and the pathogenesis is unclear. We performed a set of clinical tests to a patient with chronic and sustained hypernatremia as well as absence of thirst in order to investigate the clinical characteristics and make the diagnosis, yet most importantly to analyze the possible pathogenesis and explore a possible therapy regime.
Related JoVE Video
Burden of diabetes in the adult Chinese population: A systematic literature review and future projections.
Int J Gen Med
PUBLISHED: 06-19-2010
Show Abstract
Hide Abstract
The diabetes epidemic in China imposes an increasing burden on the health care system and the economy. We derived prospective diabetes prevalence rates in China until 2016 from a systematic review of the published literature in the period 1987-2007. The results could help to guide resources of the Chinese health care system in order to address the diabetes epidemic.
Related JoVE Video
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia.
J Obes
PUBLISHED: 06-10-2010
Show Abstract
Hide Abstract
Rimonabant, a selective cannabinoid-1 (CB1) receptor antagonist, has been shown to reduce weight and enhance improvements in cardiometabolic risk parameters in Western populations. This study assessed these effects of rimonabant in Asian population. A total of 643 patients (BMI 25?kg/m(2) or greater without diabetes) from China, Republic of Korea, and Taiwan were prescribed a hypocaloric diet (600?kcal/day deficit) and randomized to rimonabant 20?mg (n = 318) or placebo (n = 325) for 9months. The primary efficacy variable was weight change from baseline after 9 months of treatment. Results showed that rimonabant group lost more weight than placebo, (LSM ± SEM of -4.7 ± 0.3?kg vs. -1.7 ± 0.3?kg, P < .0001). The 5% and 10% responders were 2 or 3 folds more in the rimonabant group (53.0% vs. 20.0% and 21.5% vs. 5.7%, resp.) (P < .0001). Rimonabant also significantly increased HDL-cholesterol, decreased triglycerides and waist circumference,by 7.1%, 10.6%, and 2.8?cm, respectively (P < .0001). This study confirmed the comparable efficacy and safety profile of rimonabant in Asian population to Caucasians. Owing to the recent suspension of all the CB1 antagonists off the pharmaceutical market for weight reduction in Europe and USA, a perspective in drug discovery for intervening peripheral CB1 receptor in the management of obesity is discussed.
Related JoVE Video
Management of Chinese patients with type 2 diabetes, 1998-2006: the Diabcare-China surveys.
Curr Med Res Opin
PUBLISHED: 02-13-2009
Show Abstract
Hide Abstract
To describe and compare the differences in subject characteristics, glycaemic control, diabetes complications, and treatment between 1998 and 2006 in patients with type 2 diabetes.
Related JoVE Video
Cognitive function with glucose tolerance status and obesity in Chinese middle-aged and aged adults.
Aging Ment Health
Show Abstract
Hide Abstract
To evaluate the relationship of cognitive function with glucose tolerance status and obesity in Chinese middle-aged or aged adults.
Related JoVE Video

What is Visualize?

JoVE Visualize is a tool created to match the last 5 years of PubMed publications to methods in JoVE's video library.

How does it work?

We use abstracts found on PubMed and match them to JoVE videos to create a list of 10 to 30 related methods videos.

Video X seems to be unrelated to Abstract Y...

In developing our video relationships, we compare around 5 million PubMed articles to our library of over 4,500 methods videos. In some cases the language used in the PubMed abstracts makes matching that content to a JoVE video difficult. In other cases, there happens not to be any content in our video library that is relevant to the topic of a given abstract. In these cases, our algorithms are trying their best to display videos with relevant content, which can sometimes result in matched videos with only a slight relation.